Advanced search
Start date
Betweenand

Helder Takashi Imoto Nakaya

CV Lattes ORCID


Sociedade Beneficente Israelita Brasileira Albert Einstein (SBIBAE). Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)  (Institutional affiliation from the last research proposal)
Birthplace: Brazil

Dr. Helder Nakaya is a senior researcher at the Hospital Israelita Albert Einstein and a part-time professor at the Faculty of Pharmaceutical Sciences of the University of São Paulo (USP). Co-founder and chief scientific officer of the Brazilian startup D2DNA and the Danish startup Synamics Therapeutics. He is also an adjunct professor at Emory University in Atlanta, United States, and was vice-director of FCF-USP. Member of the Deliberative Council of the Brazilian Society of Immunology and the board of the Brazilian Association of Bioinformatics and Computational Biology. He was an affiliate member of the Brazilian Academy of Sciences (ABC), a consultant to CEPI (Coalition for Epidemic Preparedness Innovations) and IUIS (International Union of Immunological Societies), and a member of the scientific advisory board of the European Ebola Vaccine Consortium and the International Institute for Applied Systems Analysis (IIASA). Computational Systems Biology lab website: www.csbiology.org (Source: Lattes Curriculum)

News published in Agência FAPESP Newsletter about the researcher
More itemsLess items
Articles published in other media outlets ( ):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)
Research grants
Scholarships in Brazil
Scholarships abroad
FAPESP support in numbers * Updated December 07, 2024
Total / Available in English
Most frequent collaborators in research granted by FAPESP
Keywords used by the researcher
Por favor, reporte erros na informação da página do pesquisador utilizando este formulário.